EUVIMEDEUVIMED entdecken
Crossref

A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis

Yi Song, Zhangchi Dongye, Jiaxi Yao, Xiaonan Zhao, Tao Mo, Shiyu Yang, Cong Sun, Tingting Zhao, Jian Li, Yuzhang Wu

Science Bulletin · 2026-09 · 71 (17) · 4472-4489

DOI: 10.1016/j.scib.2026.08.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2026-09. Verfasst von Yi Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing 400038, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, RNA, Messenger, Demyelinating Diseases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Basic Science and Advanced Technology Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS). Current non-specific immunosuppressive therapies carry risks of infection and malignancy. Antigen-specific tolerance induction presents a promising alternative. Here, we developed a messenger RNA-lipid nanoparticle (mRNA-LNP) vaccine (LiH-LNPs) encoding a tandem fusion of epitopes from three MS-associated myelin antigens. LiH-LNPs alleviated inflammatory infiltration and demyelination in experimental autoimmune encephalomyelitis (EAE). Single-cell RNA sequencing revealed that LiH-LNPs reshaped the spinal cord microenvironment toward inflammation resolution by reducing the abundance and inflammatory activity of infiltrating myeloid cells and activated microglia, inducing apoptosis of encephalitogenic T cells while increasing regulatory T (Treg) cell abundance and suppressive activity. These findings provide mechanistic insights into antigen-specific immunotherapy for MS and highlight the potential application of mRNA vaccine-based antigen-specific therapy for autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalRNA, MessengerDemyelinating DiseasesNeuroinflammatory DiseasesmRNA VaccinesMultiple SclerosisAnimalsFemaleMiceImmune ToleranceT-Lymphocytes, RegulatorySpinal CordMice, Inbred C57BLNanoparticlesNanovaccinesLipidsLiposomes

Stichwörter der Autor:innen

Antigen-specific toleranceExperimental autoimmune encephalomyelitisMultiple sclerosisRegulatory T cellsmRNA-LNP vaccine

Substanzen

RNA, MessengermRNA VaccinesLipid NanoparticlesNanovaccinesLipidsLiposomes

Autor:innen und Institutionen

  • Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Chongqing International Institute for Immunology, Chongqing 401338, China. Electronic address: dongyezc@163.com.
  • Department of Urology, The First Hospital of China Medical University, Shenyang 110001, China.
  • Chongqing International Institute for Immunology, Chongqing 401338, China; School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
  • Department of Histology and Embryology, Chongqing Key Laboratory of Brain Development and Cognition, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, PLA, Third Military Medical Universi…
  • Chongqing International Institute for Immunology, Chongqing 401338, China.

Förderung

  • National Natural Science Foundation of China
  • Chongqing Basic Science and Advanced Technology Research Program

Zitieren

APA

Song, Y., Dongye, Z., Yao, J., Zhao, X., Mo, T., Yang, S., Sun, C., Zhao, T., Li, J., & Wu, Y. (2026). A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis. Science Bulletin, 71(17), 4472-4489. https://doi.org/10.1016/j.scib.2026.08.017

Vancouver

Song Y, Dongye Z, Yao J, Zhao X, Mo T, Yang S, et al. A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis. Science Bulletin. 2026;71(17):4472-4489. doi:10.1016/j.scib.2026.08.017

BibTeX
@article{Song2026,
  author = {Song, Yi and Dongye, Zhangchi and Yao, Jiaxi and Zhao, Xiaonan and Mo, Tao and Yang, Shiyu and Sun, Cong and Zhao, Tingting and Li, Jian and Wu, Yuzhang},
  title = {A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis},
  journal = {Science Bulletin},
  year = {2026},
  volume = {71},
  number = {17},
  pages = {4472--4489},
  doi = {10.1016/j.scib.2026.08.017}
}
Kostenlos starten →